LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.18 | 84.90 | 11 | 492 | 0.0223 | -0.5533 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.18 | 84.90 | 889 | 492 | 1.8056 | 1.5248 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.18 | 84.90 | 6 | 492 | 0.0122 | -0.6483 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.18 | 84.90 | 933 | 492 | 1.8950 | 1.5733 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.88 | 84.90 | 11 | 531 | 0.0207 | -0.5382 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.88 | 84.90 | 967 | 531 | 1.8211 | 1.5087 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.88 | 84.90 | 7 | 531 | 0.0132 | -0.6107 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.88 | 84.90 | 969 | 531 | 1.8249 | 1.5107 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 14.58 | 84.90 | 26 | 663 | 0.0392 | -0.3290 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 14.58 | 84.90 | 1038 | 663 | 1.5647 | 1.3258 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 14.58 | 84.90 | 9 | 663 | 0.0136 | -0.5308 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 14.58 | 84.90 | 1049 | 663 | 1.5812 | 1.3341 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.29 | 84.90 | 35 | 766 | 0.0456 | -0.2435 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.29 | 84.90 | 1108 | 766 | 1.4449 | 1.2458 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.29 | 84.90 | 16 | 766 | 0.0209 | -0.4088 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.29 | 84.90 | 1119 | 766 | 1.4592 | 1.2528 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.99 | 84.90 | 39 | 898 | 0.0434 | -0.2043 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.99 | 84.90 | 1186 | 898 | 1.3193 | 1.1696 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.99 | 84.90 | 24 | 898 | 0.0267 | -0.3100 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.99 | 84.90 | 1203 | 898 | 1.3382 | 1.1787 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 19.69 | 84.90 | 63 | 1239 | 0.0508 | -0.0742 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 19.69 | 84.90 | 1272 | 1239 | 1.0263 | 1.0135 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 19.69 | 84.90 | 28 | 1239 | 0.0226 | -0.2493 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 19.69 | 84.90 | 1293 | 1239 | 1.0432 | 1.0220 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 21.40 | 84.90 | 63 | 1454 | 0.0433 | -0.0702 | MN20160318_Q02 | C19 |